MetaCap

Regeneron Pharmaceuticals Statistics

NASDAQ: REGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

920.69-1.71 (-0.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Regeneron Pharmaceuticals by the numbers

Regeneron Pharmaceuticals has a market capitalization of $95.24 billion based on 101.63M shares outstanding. Its trailing P/E ratio is 20.4, below the 8-company peer median of 38.9, and its forward P/E is 12.8. The stock trades 11.0% above its 50-day average and 22.5% above its 200-day average.

Average daily trading volume is 805.45K shares, or about $741.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

REGN valuation vs. peer median

REGN compared with the median of 8 peer companies
MetricREGNPeer medianDifference
Market cap$95.24B$82.64B+15%
P/E (TTM)20.438.9-48%
Forward P/E12.812.1+6%
Dividend yield0.40%4.29%-91%
Avg. volume805.45K3.31M-76%

Peer median across 8 companies: GSK, SNY, BMY, TAK, VRTX, TEVA, ONC, RPRX.

Valuation

Market cap
$95.24B
Price / sales (latest FY)
6.64
EPS (TTM)
$45.24

Price and trading

Previous close
922.40
Open
936.37
Day range
916.66 – 948.42
52-week range
591.52 – 991.73
52-week change
+21.80%
Beta
—
Volume
877.67K

Dividends and events

Annual dividend
$3.70
Next earnings date
Oct 30, 2026

Additional statistics

Market Cap
95.24B
Pe
20.35
Forward Pe
12.85
Eps
45.24
Dividend Yield
41.00%
Dividend Rate
3.70
Week52 High
991.73
Week52 Low
591.52
Avg Volume
805.45K
Shares Outstanding
101.63M
Ma50
829.76
Ma200
751.41
Earnings Date
Oct 30, 2026
Pct From52w High
-7.16%
Pct From52w Low
55.65%

Related